Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Robert Desantis also recently made the following trade(s):
- On Friday, October 25th, Robert Desantis sold 1,012 shares of Intuitive Surgical stock. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00.
- On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The stock was sold at an average price of $477.50, for a total transaction of $113,645.00.
- On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48.
- On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The stock was sold at an average price of $486.88, for a total value of $192,804.48.
- On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total value of $111,542.40.
Intuitive Surgical Trading Up 1.1 %
Intuitive Surgical stock traded up $5.43 during trading on Tuesday, hitting $516.31. 1,064,808 shares of the company were exchanged, compared to its average volume of 1,464,542. The company has a market capitalization of $183.90 billion, a P/E ratio of 82.14, a PEG ratio of 5.11 and a beta of 1.39. The business’s 50 day moving average is $488.56 and its 200 day moving average is $443.89. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $523.34.
Institutional Trading of Intuitive Surgical
Analyst Ratings Changes
ISRG has been the topic of several recent analyst reports. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Barclays increased their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Morgan Stanley increased their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research report on Monday, July 15th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $513.74.
View Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- The 3 Best Blue-Chip Stocks to Buy Now
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What Do S&P 500 Stocks Tell Investors About the Market?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Stock Sentiment Analysis: How it Works
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.